Skip directly to content


Vyndaqel® - a convenient single-capsule, once-daily dose for patients with stage 1 ATTR-PN2

Many ATTR-PN patients experience cardiac disease, which is a major cause of death. Consider the potential of ATTN-CM in hereditary disease, which may require a higher dose of VyndamaxTM.4,5

* Capsule shown is not actual size.